Resmed Inc. buy KeyCorp
Start price
02.08.24
/
50%
€203.50
Target price
02.08.25
€230.02
Performance (%)
17.94%
End price
03.08.25
€240.00
Summary
This prediction ended on 03.08.25 with a price of €240.00. The prediction had a final performance of 17.94%. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.48 was paid as dividends for this prediction. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 2.254% | 2.254% | -5.830% |
| iShares Core DAX® | 1.822% | 3.926% | 23.507% |
| iShares Nasdaq 100 | 1.093% | -0.585% | 6.034% |
| iShares Nikkei 225® | 3.042% | 1.335% | 17.437% |
| iShares S&P 500 | 1.247% | 0.836% | 4.374% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $238.00 to $251.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten